PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
08-Sep-2023 ABPI response: UK joins Horizon Europe ABPI
08-Sep-2023 AMO Pharma Announces Affirming Data from REACH-CDM Clinical Trial for AMO-02 in Treatment of Myotonic Dystrophy AMO Pharma
08-Sep-2023 Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update Adrenomed AG
08-Sep-2023 Dominik Arnold to become new CEO of the COLTENE Group COLTENE Holding AG
07-Sep-2023 Pleco Therapeutics Announces the Appointment of Dr Henno Welgemoed as Chief Medical Officer Pleco Therapeutics
07-Sep-2023 MPH Health Care AG: Half-year result 2023 MPH Health Care AG
07-Sep-2023 Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo Biotest AG
07-Sep-2023 Abivax provides business and operational update ABIVAX
06-Sep-2023 Engitix Announces Appointment of Christopher Stevenson Ph.D., as Chief Scientific Officer Engitix Ltd
06-Sep-2023 Novel Molecular Design for Enhanced Efficacy and Safety in Radiotheranostics Chiba University, Japan
06-Sep-2023 Bloomsbury Genetic Therapies Announces New Program in Parkinson’s Disease Bloomsbury Genetic Therapies Limited
06-Sep-2023 AI in BioMed Economy Surpasses $2.5 Trillion in 2023, Set to Reach $6 Trillion by 2027 Global AI Ecosystem
06-Sep-2023 Pleco Therapeutics Announces the Appointment of Dr Henno Welgemoed as Chief Medical Officer Pleco Therapeutics
06-Sep-2023 Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin® Ligand Discovery Using Cutting-Edge AI and Molecular Modeling Techniques Navigo Proteins
06-Sep-2023 Vicore Pharma Announces Presentations at the European Respiratory Society (ERS) International Congress 2023 Vicore Pharma
06-Sep-2023 Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin® Ligand Discovery Using Cutting-Edge AI and Molecular Modeling Techniques B3C newswire
06-Sep-2023 Evolva receives approval for Veri-teTM Resveratrol in Thailand Evolva Holding SA
05-Sep-2023 Biomunex is nominated for the Prix Galien USA in the "Best Startup" category, further recognizing the innovative nature of its bi- and multi-specific antibody technologies in immunotherapy of cancer Biomunex
05-Sep-2023 Epigenomics AG: Pareto and Warburg publish analyst research reports Epigenomics AG
05-Sep-2023 Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia Zenas BioPharma